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This paper is a surgical overview of adrenal
gland disorders and emphasizes new developments
in diagnosis and management. Adrenal disorders are
relatively rare but clinically, they are very important.
If they go undetected, they can produce severe metabolic disturbances which may be fatal.
Indications for Adrenal Surgery. (Table 1)

Metastatic Breast Cancer. Today, the most common indication for adrenal surgery is metastatic
breast cancer. At our institution 10'-15 bilateral adreilalectomi.es are performed each year for this reason.
Breast cancer is the number one cancer in women.
There are approximately 70,000 new cases each
year; unfortunately, 60 % of these cases, or 42,000,
will develop metastases at some time and will become candidates for palliative treatment. Some of
these tumors are estrogen dependent, and this is the
rationale for removing the two main sources of
estrogen-the ovaries and the adrenals. If the ovaries
are still present at the time of the adrenalectomy,
they are removed. This procedure is not performed
if the patient has hepatic or pulmonary insufficiency
or advanced brain metastases. Forty percent of the
patients with metastatic breast cancer experience a
clear-cut response with a decrease in the size of all
lesions and no new disease. This status has been
maintained for at least six months. Five percent have
an arrest of their tumors and the remaining 55%
have had no response. In the responder group, 55 %
are still alive two years after adrenalectomy. In the
non-responder group, almost all of the patients have
died; only 4 % have survived for two years.
Metastatic Prostatic Cancer. In metastatic prostatic cancer, bilateral adrenalectomy never gained
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wide acceptance by urologists, and it is rarely performed today. Its effectiveness is difficult to assess
since there are only a few widely scattered reports
in the literature. Although this operation was used
occasionally as a primary form of treatment in patients with advanced prostatic cancer, it was usually
employed in those patients who relapsed after an
initial favorable response to orchidectomy-estrogen
treatment. In these proven androgen-dependent tumors, it was hoped that a further lowering of androgen production might produce a second clinical
remission. This hope was never realized, but it is
reported that more than one-half of those patients
treated with adrenalectomy experienced a transient
response, usually relief of bone pain.
Adrenal Cysts. The most common type of
adrenal cyst seen clinically is the pseudocyst due to a
hemorrhage into a normal adrenal gland or into an
adrenal tumor. One interesting form of this cyst, for
which one should be on the lookout, is calcified
adrenal hemorrhage in the newborn. These newborns are found to have a mass above one or both
kidneys often outlined by a rim of calcification.
Usually, there is no evidence of adrenal insufficiency
or excessive blood loss. The etiology is thought to
be trauma since most of these babies are the product
of a difficult breech delivery. If the diagnosis is
secure, surgery is not necessary.
Pheochromocytoma. Pheochromocytoma, a neural crest tumor, is the best defined cause of curable
hypertension today and accounts for about 0.5% of
all cases of hypertension. At the present time, we
have the capability of diagnosing 100% of these
tumors with relatively simple, safe and inexpensive
biochemical tests. Despite the ability to diagnose
these tumors, however, an estimated 1,000 persons
die each year in the United States from complications of unrecognized pheochromocytoma. Surgery
is particularly hazardous in patients with unsuspected
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TABLE 1.
INDICATIONS FOR ADRENAL SURGERY

1. Palliation of hormonally dependent tumors
A. Metastatic breast cancer
B. Metastatic prostatic cancer
2. Adrenal cysts
hyperplasia
3. Hyperfunction of the adrenal cortex due to ~ade~oma
carcinoma
A. Cushing's syndrome
B. Primary aldosteronism
C. Virilization (adrenogenital syndrome)
D. Feminization in men
4. Tumors of the adrenal medulla
A. Benign-pheochromocytoma, ganglioneuroma
B. Malignant-neuroblastoma

pheochromocytoma, and the death rate in one such
series was 50%. Before the availability of adrenolytic drugs, elective removal of a pheochromocytoma
carried a mortality rate of 25 % . Today, with careful
management, the mortality rate is around 1 % .
Conditions Requiring Chemical Screening for
Pheochromocytoma. Table 2 shows the chemical
tests that are now used as screening tests. These tests
are replacing the pharmacologic tests, regitine and
histamine, that were used regularly until just a few
years ago.
Most patients have intermittent rather than
persistent symptoms, and these so-called "spells" or

TABLE 2.
CONDITIONS REQUIRING CHEMICAL SCREENING FOR
PHEOCHROMOCYTOMA

1. Hypertension-sustained or paroxysmal
2. Sudden attacks or spells precipitated by physical exertion
or excitement
A. Symptoms accompanying attacks-headaches, perspiration, pallor or flushing, nausea or vomiting, dizziness, fainting
3. Hyper- or hypotension associated with trauma, anesthesia, or parturition
4. Hypermetabolic state
5. Relative with proven pheochromocytoma
6. Neurqcutaneous syndrome (von Hippe! Lindau's or von
Recklinghausen's)

attacks have certain characteristics. They appear
suddenly and usually last less than an hour, often
for only 15-30 minutes. Usually two or more symptoms are experienced together, and each spell tends
to be a carbon copy of the previous one. The most
common symptoms are headache, perspiration, palpitation and pallor. The frequency of these attacks
is quite variable, and about one-quarter of the patients will have one or more each day and about
two-thirds will have one or more each week.
With .the chronic outpouring of catecholamines
causing a hypermetabolic state, these patients may
be hiding under the diagnosis of hyperthyroidism or
diabetes mellitus. The hypermetabolic state results
in many of these patients being on the thin side in
marked contrast to the majority of patients with
essential hypertension who are overweight.
This disease is frequently familial and in our
somewhat atypical series about one-half are of this
type. One family in particular, the McCoys, has been
particularly productive with 10 of 28 members having pheochromocytoma. The famous Hatfield-McCoy feud was probably fueled by the high incidence
of this tumor in the combatants.
The association of this tumor with neurocutaneous diseases and with other tumors of neuroectodermal origin, such as thyroid and parathyroid,
is well established and probably results from their
common embryological origin.
Diagnosis. The diagnosis of pheochromocytoma
today hinges on biochemical confirmation of the over
production of catecholamines. Urine normally contains small quantities of the free catecholamines and
their metabolites-the metanephrines and 3-methoxy-4-hydroxy-mendelic acid (VMA). The excretion
of all three of these compounds is persistently high
in almost every patient with pheochromocytoma,
even those with paroxysmal hypertension. Each test
is more than 90% accurate, with the free catechol
determination being the most accurate, around 99 % ;
metanephrine is 97 % accurate, and VMA is 90%
accurate. There are no reported cases of pheochromocytoma with negative tests for all three determinations. At the University of Virginia, we rely on free
catechols and VMA.
Pharmacological tests are not recommended
because they are more hazardous, more expensive,
and less accurate than urinary assays. In a series of
patients from the National Institute of Health, 25 %
of the patients with proven pheochromocytoma had
negative pharmacological tests. Since the diagnosis
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of pheochromocytoma depends upon the accuracy
of biochemical tests, it is important to take a careful
drug history, for all three determinations are subject
to error if certain drugs have been taken.
Location of Tumor. The pheochromocytoma
is known as the 10% tumor-10% multiple, 10%
extra-adrenal, and 10% malignant. Multiple tumors
are mote apt to occur in children and in familial
pheochromocytoma with reported incidences of 2050%.
Extra-Adrenal Chromaffin Tumors. The chest
is the most common site of the tumors, except for
the abdomen, and accounts for 1-2% of them. These
tumors usually present as posterior, mediastinal,
paravertebral masses readily detected by appropriate
chest x-rays. The rare tumors in the neck are palpable. Bladder pheochromocytomas are of particular
interest. Patients often complain of headache with
or after voiding. Fifty percent of the patients with
bladder pheochromocytomas have hematuria. These
tumors are usually not visible on cystoendoscopy,
since they are located in the muscle wall.
Localization of the Tumor. Once the diagnosis
of pheochromocytoma is established by chemical
means, we do not make a special effort to localize
the site of the tumor. There are two reasons for this
approach: 1) At surgery, we always examine both
the adrenal glands and the para-aortic and pelvic
regions, the usual sites for intra-abdominal pheochromocytomas, 2) All of our efforts are directed
at avoiding stimulation of the tumor with catecholamine release, and diagnostic procedures such as
angiography and retroperitoneal gas insuffiation often
stimulate the tumor and have caused some deaths.
Our radiological work-up consists of chest
x-rays to rule out the 1-2% intrathoracic tumors,
and a double dose IVP with tomography to look for
depression and flattening of the upper pole of the
kidney. We do not perform arteriography, venography, or gas studies. If arteriography is planned,
be sure your patient is on protective pharmacologic
blockade with alpha blocker phenoxybenzamine
(dibenzyline) and have an i.v. in place with both
alpha and beta blockers available in the x-ray suite.
We get some help in localization from our
urinary catechol determinations. If the urine contains
increased amounts of epinephrine, as well as norepinephrine (NE), 90 % will be found in the adrenal
gland, 10% in the organs of the Zuckerkandl, those
tiny chromaffin bodies near the origin of the inferior
mesenteric artery. If the urine contains increased
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TABLE 3.
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA

Preoperatively
1. Phatmacologic blockade
A. Partial alpha adrenergic blockade using long-acting
phenoxybenzamine (dibenzyline)
1) Blood pressure is lowered to normal or near
normal levels.
2) Symptoms are lessened.
3) Plasma volume is expanded with resultant drop in
hema tocrit of 5-10%.
4) Surgical course is smoother and less hazardous.
B. Beta adrenergic blockade is used only in selected cases.
1) Persistent tachycardia or arrhythmia despite
adequate alpha adrenergic blockade

2. Transfusion of packed RBC's as indicated by the fall
in hematocrit

TABLE 4.
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA

Surgery
1. Continuous monitoring of blood pressure, central venous
pressure and cardiac activity is established prior to inductien.
A. Arterial pressure-intra-arterial catheter for a continuous readout and recording when desired
B. Central venous pressure- catheter is inserted in
the external jugular vein.
C. Cardiac activity- continuous ECG observation

2. Minimize or avoid stimuli known to cause tumor to
release catecholamines.
A. Positioning of the patient
B. Muscle twitching
C. Hypercarbia ot hypoxia
D . Intubation
E. Drugs- curare, cyclopropane
3. Premedication
A. Drying agent- atropine or scopolamine
B. Narcotic- morphine
C. Tranquilizer-Valium ®
4. Anesthetic technique
A. General anesthesia rather than block
B. Induction- thiopental (Sodium Pentothal ®)
C. Intubation- succinylcholine following small dose of
pancuroiiium to avoid muscle fasciculations
D. Agent of choice-halothane
E. Maintenance of relaxation during surgery- pancuronium
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amounts of NE only, however, be prepared for a
more extensive search of the abdomen, for only
60-70% of these tumors reside in the adrenal gland.
This reflects the fact that extra-adrenal chromaffin
tissue elaborates NE almost exclusively. Plasma
catechol determinations via vena cava sampling at
different levels are reserved for those patients requiring a second surgical exploration for pheochromocytoma-either for recurrent tumor or for a
previously missed tumor.
Management of Patients with Pheochromocytoma-Preoperative. (Table 3) The primary aini
of the preoperative preparation and the anesthetic
management is to minimize stimuli to the pheochromocytoma to prevent sudden and dangerous alterations in heart rate, rhythm, and arterial pressure.
The key point of preoperative preparation is partial
alpha adrenergic blockade. This usually takes folirto-five days tb accomplish, but it is well worth the
effort primarily because it takes most of the risk out
of surgery. I emphasize the word partial, for if you
had total blockade, you would lose two very helpful
diagnostic signs-a rise in blood pressure on manipulation of the tumor and a drop in blood pressure
after the removal of the tumor. Sometimes extraadrenal tumors are difficult to locate, and it is very
helpful to be able to gently palpate the para-aortic
and pelvic areas seeking a blood pressure respcmse.
Beta blockade is not useful for preoperative preparation.
Management of Patients with Pheochromocytoma-Surgery. (Table 4) Surgery is our current
way of handling pheochromocytoma patients, but I
would like to emphasize that there is no single
anesthetic agent or technique which is the sine qua
non of anesthesia for pheochromocytoma. It is important to establish your monitoring prior to induction, for this is almost as tumor-stimulating as
manipulation of the . tumor itself during surgery.
We have been happy with halothane. It elicits
no sympathoadrenal activity and it decreases the
peripheral vasculature response to NE. There is
some evidence that it may make the heart more
irritable and more prone to cardiac arrhythmia, but
this has not been our experience. Methoxyflurane was
touted as the anesthetic agent of choice for several
years, but it is infrequently used nowadays because
of some reports that it caused high output renal
failure.
I think the use of pancuronium during intubation is an excellent example of the very careful
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anesthetic technique required. Commonly during
intubation with succinylcholine, there are transient
muscle fasciculations which may stimulate the tumor,
so to avoid this possibility, pancuronium is given
ahead of time.
We always use a subcostal incision in these
patients, inspecting and palpating the pelvic and
para-aortic region and both adrenal glands. We try to
manipulate the tumor as little as possible. The single
adrenal vein is ligated first if feasible. If only one
adrenal is involved, the entire adrenal gland is removed. If this is the oµly tumor, there is generally
a significant drop in arterial pressure which is usually
corrected by volume replacement. If arterial pressure
does not drop or if, after a short period of hypotensiori, it bounces back up to supernormal levels, you
had better look around for a second tumor. Remember that 10% of patients will have more than one
tumor, and if your patient is a child or has familial
pheochromocytoma; the probability of a second tilmor increases to 20-50%.
Management of Patients with Pheochroniocytoma-Problems in the Operating Room. (Table
5) When manipulatiori of the tumor causes arterial
pressure to shoot up to levels of 250/150 or higher,
the surgeon's catechol level is not far behind. We
rely primarily on phentolamine drip in this situation,
but if we are at all worried, we do not hesitate to

TABLE 5.
MANAGEMENT OF PATIENTS WITH PHEOCHROMOCYTOMA

Cardiovascular Problems During Surgery
1. Hypertension

A. Phentolamine drip-short-acting alpha adrenergic
blocker
B. Sodium nitroprusside-direct smooth muscle relaxant
C. Deepen anesthesia with halothane.
2. Hypofension after removal of the tumor
A. Volume expansion with blood, plasma, albumin and
lactated Ringer's solution
B. Neo-synephrine ® or norepinephrine drip- alpha
adrenergic stimulators
3. Arrhythmias
A. Lidocaine intravenously, bolus or drip
B. Propanolol intravenously, bolus or drip- beta adrenergic blocker
C. Reduce halothane concentration.
D. Check blood gases to rule out hypercarbia and / or
hypoxia.
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use nitroprusside. Sodium nitroprusside effectively
lowers arterial pressure by direct action on smooth
muscle allowing you to titrate the pressure down to
the level you desire.
Hypotension is not the problem it used to be
thanks to preoperative alpha adrenergic blockade.
In most cases, volume expansion, usually with albumin and Ringer's lactate, corrects the hypotension.
Cardiac arrhythmias worry me a lot· more than
hyper- or hypotension. We reduce the halothane
concentration and give lidocaine initially and if this
solves the problem-fine. Lidocaine, though, is
really a minor league drug in this situation and if
the arrythmia does not respond fairly promptly to
lidocaine plus the decreased halothane concentration,
1-2 mg of the beta blocker, propanolol, often gives
dramatic relief.
Primary Aldosteronism. This interesting syndrome, first identified by Conn in 1954, is another
cause of curable hypertension, probably accounting
for 2-3 % of all ·hypertension. Unlike the hypertension seen with pheochromocytoma, it is always sustained and usually benign with diastolic pressures
usually less than 130 mm.
Physiology Na·-K·-H+. The phenomenon of
renal escape is important because of its clinical
implications. Aldosterone acts primarily on the distal
renal tubule causing retention of Na• and H 2 0 while
enhancing the excretion of K• and H•. If this ion
exchange continued unchecked, the- retention of Na•
and H 20 would necessarily result in massive edema,
but this does not take place. Patients with primary
aldosteronism do not have edema. After two-tothree days of a'ldosterone, the kidneys escape from
the Na• retaining effect but they do not escape from
the K• losing effect of the hormone. Initially, salt
and H 2 0 retention take place, the ECF compartment
is expanded, and the patient gains around 2 kg. At
this point, however, three-to-five days ·after administration of aldosterone, renal escape is complete and
urinary Na• levels, initially low, go back up to normal and Na• equilibrium is established at a higher
level. The exact mechanism of renal escape has not
been clarified. Aldosterone does not lose its Na•
retaining effect on the distal tubµle but there is
decreased reabsorption of Na• by the proximal
tubule, probably secondary to the action of volume
sensitive salt-losing hormone referred to as the third
factor. The decreased reabsorption of Na• by the
proximal tubule throws an added load on the distal
tubule, and this added load balances out the en-
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hanced Na• reabsorption due to aldosterone. The net
result is normal urinary Na•.
Aldosterone is an unusually potent hormone.
Each day, only 0.1 mg is produced, and chronic
production of as little as 0.2 mg per day, only two
times the usual output, can cause primary aldosteronism. This amount can be produced by a tiny
adenoma less than 2 mm in size. Because of the
hormone's potency, most adenomas found at surgery are small. Whereas the average size of a pheochromocytoma is around 100 g, 85 % of these 1adenomas are less than 10 g and 75% are less than
3 cm in diameter.
Renal-Adrenal Interaction. There are only three
direct stimuli to aldosterone production, adrenocorticotropic hormone (ACTH), K+, and angiotensin II. ACTH is of little importance in the day-today aldosterone output, since it stimulates aldosterone release only in emergency or acute situations and
for only a short period of time. In normal man, the
renin-angiotensin system and K+regulate aldosterone
secretion through negative feedback loops. If hyperkalemia is present, the increased aldosterone production enhances the urinary excretion of K+, returning
plasma K• levels toward normal, thereby removing
the stimulus. When the effective blood volume is reduced, the renin-angiotensin system increases aldosterone production and the resultant retention of Na•
and H 20 returns the blood volume toward normal
and shuts off the renin-angiotensin system.
In patients with malignant hypertension or in
other disorders associated with chronic underperfusion of the kidneys, renin, angiotensin II, and aldosterone levels are chronically high and the induced
alqosteronism is unable to shut off the renin mechanism. This is called secondary flldosteronism.
Classification of Aldosteronism. (Table 6)
Until fairly recently, primary aldosteronism was a
pretty clear-cut syndrome. The patients, more commonly women 30- 50 years old, had longstanding
hypertension with associated hypokalemia and
muscle weakness. Surgical removal of a small adenoma almost invariably corrected the hypertension
and the hypokalemia.
The first cloud on the horizon was the report
of many patients with normokalemic primary aldosteronism. Some of these represent milder forms of
the syndrome, but many times these patients remain
normokalemic because they have been placed on a
low salt diet. The magnitude of the K•/ Na• exchange
is directly related to the number of Na• reaching the
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TABLE 6.
CLASSIFICATION OF ALDOSTERONISM

Primary Aldosteronism
1. Benign adrenocortical adenoma-75%
2. Adrenocortical hyperplasia or hyperfunction-25 %
A. Idiopathic
B. DOCA-remediable
C. Glucocorticoid-re~ediable
3. Adrenocortical carcinoma
Secondary Aldosteronism
angiotensin II

1. Physiologic via three known

direct~ potassium

stimuli

ACTH

A. Renin-angiotensin system

1) Reduced plasma volume-hemorrhage, dehydration, low salt diet, upright posture
B. Potassium
1) High potassium diet
C. ACTH
1) Stress-surgery, trauma, anxiety
2. Pathologic
A. With hypertension
1) Malignant hypertension
2) Renal vascular hypertension
3) Oral contraceptive hypertension
8. Without hypertension
1) Juxtaglomerular hyperplasia
2) Cirrhosis with ascites
3) Nephrosis

distal tubule. A low salt diet would limit this ion
exchange and blunt or obscure the clinical picture.
Many of these normokalemic patients exhibit hypokalemia after several weeks on a high salt diet.
In the last few years, it has become apparent
that hyperplasia is responsible for many cases of
primary aldosteronism, and current estimates suggest that 25 % are due to hyperplasia or hyperfunction, and the final figure may go even higher. This
relatively high incidence of hyperplasia is very important, for these patients are treated medically, not
surgically. If bilateral adrenalectomy is performed
on these patients, the hypokalemia is corrected but
the hypertension is not.
At present, the idiopathic and DOCA remediable forms of hyperplasia are treated with spironolactone, · an aldosterone antagonist which blocks
aldosterone at the renal tubule. The gluco-corticoid
remediable form, or A-G syndrome, is treated with
dexamethasone.

In the secondary forms of aldosteronism,
either physiologic or pathologic, the aldosterone is
elevated because the renin-angiotensin system is fn
high gear. As a result, patients with this condition
have higher levels of renin, angiotensin II, and
aldosterone.
Diagnostic Studies. (Table 7) Before performing the screening test, the patient should be off all
medication, particularly the thiazide diuretics, for a
minimum of two weeks.
A high salt diet is used for two reasons. In
normal people, a high salt diet expands the ECF
volume, thereby suppressing the renin-angiotensin
mechanism and decreasing the secretion of aldosterone. With low secretion rates of aldosterone,
urinary K• levels are low and plasma K• levels remain
unchanged. In patients with primary aldosteronism,
the autonomous production of aldosterone is not
suppressed by the high salt diet, and the availability
of plenty of Na• permits the aldosterone present to
exert its maximal effects. With the K•/Na• exchange
operating maximally, the resultant high urinary excretion of K• causes hypolmlemia.
The first step in making the definitive diagnosis
is to prove that the patient has excess aldosterone in
the urine. To widen the gap between normal patients
and those with primary aldosteronism, this determination is performed while the patient is on a high
salt diet. Once you have established that the patient
is overproducing aldosterone, you then must separate
primary from secondary forms. The high aldosterone

TABLE 7.
STUDIES TO DETECT PRIMARY ALDOSTERONISM

I. Screening Test
A. Determine plasma potassium concentration after two
weeks on a high salt, moderate potassium diet.
1) If plasma potassium is <3.5 mEq/ L, patient may
have aldosteronism.
2) If plasma potassium is >3.5 mEq / L, patient does
not have aldosteronism.
2. Diagnosis
A. Nonmalignant hypertension
B. Overproduction of aldosterone
1) Failure to suppress abnormal aldosterone
production with a high salt diet
C. Underproduction of renin
1) Failure to stimulate renin production with a low
salt diet and upright position
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levels seen in secondary aldosteronism are due to
overactivity of the renln-angiotensin system, so that
these patients all have abnormally high levels of
renin. In patients with primary aldosteronism, the
chronic overexpansion of the ECF suppresses the
renin-angiotensin mechanism and renin levels are
low. To widen the gap between normal and primary
aldosteronism, this determination is performed while
the patient is on a low salt diet and after three-tofour hours in the upright position. These two maneuvers double and triple the output of renin in normal
individuals but have little or no effect on patients
with primary aldosteronism.
Diagnostic Studies. Since the majority of these
tumors are small and relatively hypovascular, they
are not detectable by the usual techniques-IVP,
nephrotomography, arteriography, or retroperitoneal
pneumography. It is important to prove the presence
of an adenoma, since surgery is not the treatment of
choice for hyperplasia-induced primary aldosteronism.
There are three special techniques available for
lateralization. Adrenal venography successfully outlines the adenoma in around 85 % of the cases.
Adrenal venous blood is sampled at the time of
venography, and if you detect high levels of aldosterone on the side of the lesion, with close to
peripheral levels on the unaffected side, the accuracy
of diagnosis approaches 100% .
A recently introduced scanning test, presently
expensive and unavailable except at a few selected
medical centers, may become the best diagnostic tool
of the future. Its obvious appeal is its complete
safety. Photo scanning is performed after administration of 19-iodocholesterol labeled with radioactive
iodine !1 31 • Lugols is given ahead of time to block
1

229

the uptake of iodine by the thyroid. The kidney areas
are localized with Hg chlormerodrin scan. Five-tosix and eight-to-ten days after administration of
radioactive material, scanning of both adrenals is
accomplished using a computer-assisted Anger
gamma camera.
Surgery. Preoperative preparation is aimed at
correcting the hypokalemia. Hypolcalemia increases
the irritability of the heart so that surgery might
cause ventricular fibrillation or other arrhythmia.
Hypokalemia also weakens the muscles, increasing
the danger of respiratory insufficiency if curare-like
agents are used.
Hypokalemia may be corrected in two ways.
Spironolactone, aldosterone blocker, reverses the effects of aldosterone and returns plasma K+ levels to
normal in three-to-four days. Low salt-high K+ diet
also returns the plasma K+ to the normal range but
this takes a little longer, usually seven-to-eight days.
We prefer the dietary approach since it is more
predictable.
We prefer the transabdominal approach because it allows us to eX'amine carefully both adrenal
glands before making any decision. These tumors
occur only in the adrenal glands and 94% are unilateral. If aldosterone tumor is clearly visualized on
one side, it would be feasible to perform a unilateral adrenalectomy via the flank approach since
less than 6% are bilateral. Because these tumors
are so small, you have to free the gland sufficiently
to permit inspection and palpation of the entire
gland. As the lateralization techniques-venography
and adrenal scanning-become more usable, a flank
approach might be preferred. Unlike other forms of
curable hypertension, the blood pressure usually
takes weeks-to-months in returning to normal levels.
1
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